Publications en collaboration avec des chercheurs de Universidad Rey Juan Carlos (29)

2024

  1. Early in vivo detection of denervation-induced atrophy by luminescence transient nanothermometry

    Journal of Biophotonics, Vol. 17, Núm. 2

2023

  1. Hospitalization Burden of Patients with Kidney Stones and Metabolic Comorbidities in Spain during the Period 2017–2020

    Metabolites, Vol. 13, Núm. 4

  2. Time-Dependent Changes in Muscle IGF1-IGFBP5-PAPP System after Sciatic Denervation

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2022

  1. Endothelial Dysfunction: An Intermediate Clinical Feature between Urolithiasis and Cardiovascular Diseases

    International Journal of Molecular Sciences, Vol. 23, Núm. 2

  2. Exploring new kingdoms: The role of extracellular vesicles in oxi-inflamm-aging related to cardiorenal syndrome

    Antioxidants, Vol. 11, Núm. 1

  3. Hyperoxaluria Induces Endothelial Dysfunction in Preglomerular Arteries: Involvement of Oxidative Stress

    Cells, Vol. 11, Núm. 15

  4. Special Issue “Oxidative Stress in Aging and Associated Chronic Diseases”

    Antioxidants

  5. “Shikonin inhibits microglia activation and reduces CFA-induced mechanical hyperalgesia in an animal model of pain”

    Biomedicine and Pharmacotherapy, Vol. 150

2021

  1. Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease

    European Journal of Pharmacology, Vol. 895

  2. Changes in the Objective Structured Clinical Examination (OSCE) of University Schools of Medicine during COVID-19. Experience with a computer-based case simulation OSCE (CCS-OSCE)

    Revista Clinica Espanola, Vol. 221, Núm. 8, pp. 456-463

  3. Urolithiasis develops endothelial dysfunction as a clinical feature

    Antioxidants, Vol. 10, Núm. 5

2020

  1. Myeloid GRK2 regulates obesity-induced endothelial dysfunction by modulating inflammatory responses in perivascular adipose tissue

    Antioxidants, Vol. 9, Núm. 10, pp. 1-17

2018

  1. MPGES-1 (Microsomal prostaglandin E synthase-1) mediates vascular dysfunction in hypertension through oxidative stress

    Hypertension, Vol. 72, Núm. 2, pp. 492-502

2017

  1. Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance

    Cell Metabolism, Vol. 26, Núm. 1, pp. 212-229.e12

  2. Melanocortin-4 receptor agonist (RO27-3225) ameliorates soleus but not gastrocnemius atrophy in arthritic rats

    Journal of Physiology and Pharmacology, Vol. 68, Núm. 2, pp. 191-199

2016

  1. Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 310, Núm. 11, pp. E925-E937

  2. Hypothalamus and thermogenesis: Heating the BAT, browning the WAT

    Molecular and Cellular Endocrinology, Vol. 438, pp. 107-115

  3. Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension

    British Journal of Pharmacology, Vol. 173, Núm. 9, pp. 1541-1555

  4. The melanocortin receptor type 3 agonist d-Trp(8)-γMSH decreases inflammation and muscle wasting in arthritic rats

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 7, Núm. 1, pp. 79-89

2015

  1. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension

    British Journal of Pharmacology, Vol. 172, Núm. 12, pp. 3159-3176